Respiratory exacerbations - definitions and therapy

P. Flume (Charleston, United States of America), L. Naehrlich (Giessen, Germany)

Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children
Session: PG10 Cystic fibrosis: Basic defects and clinical problems in children
Session type: Postgraduate Course
Number: 109
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Flume (Charleston, United States of America), L. Naehrlich (Giessen, Germany). Respiratory exacerbations - definitions and therapy. International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


Neural respiratory drive during recovery from exacerbations of COPD
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013


Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014


Impact of mucolytic treatment on COPD exacerbations
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Inter-relationship of different types of respiratory symptoms in COPD
Source: International Congress 2014 – Comorbidities
Year: 2014

Is therapy adherence to inhaled corticosteroids related to hospitalization, pneumonia or mortality in COPD?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014

Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Is restricted transfusion approach in the ICU appropriate also for COPD exacerbations?
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015


Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Gait speed is a predictor of readmission following hospitalisation for acute exacerbations of COPD
Source: International Congress 2014 – Best abstracts in physical activity and exercise testing
Year: 2014

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Hospital treatment costs of exacerbations in COPD patients with indications for LTOT
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Is therapy adherence with inhaled tiotropium in COPD related to hospitalization, pneumonia or mortality?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014